Technology & Products

GRACE Laboratories, LLC, has patented several technologies (5 international patents) focusing on blood assays for traumatic brain injury (TBI) and assessment of post-traumatic seizures.

• TBI-GRACE Test detects AMPA receptor peptide fragments (CE Marking for EU distribution)
• Epi-GRACE Test detects antibodies directed against the AMPA receptor (CE Marking for EU distribution)
• PNS-GRACE Test detects NMDA receptors

These inexpensive, rapid, and easy-to-use test kits can be used in emergency settings (trauma centers, emergency departments), primary care offices, and hospital clinical laboratories (for inpatient and outpatient care). 

Home

Scientific Background

Technology & Products

Business Development

Publications

Media

Education

About Us

Contact Us